Excerpts

A decreasing trend was noted in the population of CD3 + CD4 + CD69 + cells in HT2 vs.

For IL-10 mRNA there was a highly significant difference between stage III patients on one hand and stage I and II patients on the other.

While most severe COVID-19 patients showed a trend toward normalization of PTX-3 levels at 10 months post-infection, a substantial subset still presented with serum concentrations exceeding 5000 pg/ml ( Figure 3 ).

Significance was considered with any value with an FDR < 0.05, and a statistical trend was considered for any value with an FDR < 0.1.

There was also a significant decrease in production of IL-1ra, G-CSF, and MIP-1β and a decreasing trend in production of IL-17A, IP-10, and TNF in these cells.

0.05 ≤ P value < 0.10 as indicative of borderline significance.

Clinically, ABO antibodies are highly significant, as both IgM and IgG subclasses can effectively activate complement and cause acute hemolytic reactions ( 21 , 22 ).

Quantitative analysis showed a trend toward reduced regenerative area in SKLT-treated animals, though this reduction did not reach statistical significance ( Figure 1C ).

Notably, like 2-DG, there was also a strong trend for reduced expression of IL1B along with IL6 mRNA following addition of Eto ( Figure 2A ), although the reverse was seen in terms of secretion ( Supplementary Figure 3 ).

Although lactate dehydrogenase (LDH) did not return to normal, a decreasing trend was observed.

Specifically, the proportion of patients with advanced T stage, clinical stage, and high histological grade increased from C1 to C2 and then to C3, reflecting an increasing trend in tumor malignancy, indicating that our molecular classification accurately captures and reflects the continuum of HCC clinical aggressiveness.

Several proteins displayed a positive trend across the phenotypes from NoAPS to MAPS ( Figure 1E , top panel), while others showed a negative trend ( Figure 1E , lower panel), suggesting an association with clinical severity of APS.

From day 15 of treatment onward, we observed a notable trend of tumor suppression in the PTE treatment group ( Figure 7B ), accompanied by significant reductions in tumor volume ( Figures 7B, C ) and overall tumor weight ( Figure 7D ).

Notably, several inflammatory proteins showed a trend toward normalization, which might have reached statistical significance in a bigger sample size.

Within the TCGA-LIHC cohort, the expression of MFSD12 demonstrated highly significant positive correlations with the transcript levels of these immune-checkpoint molecules ( Figure 9B ).

also observed a favorable trend of BBs use in ICIs-treated lung cancer patients, but it was not statistically significant ( 11 ); our larger sample and rigorous methodology likely yield more reliable results. β-adrenergic receptors (β-AR) are widely expressed in tumor cells, immune cells, and vascular endothelial cells.

Furthermore, we highlighted 15 drugs from the GDSC database that exhibited highly significant differences in sensitivity between the high MitoScore and low MitoScore subgroups.

In contrast, the network meta-analysis showed a trend toward PFS benefit for amiva-lazer-chemo but did not reach statistical significance, potentially due to limited sample sizes in both analyses.

HM demonstrated a significant trend toward superior efficacy in reducing tissue histamine compared to OM.

It was found that the PLS-DA plot showed a clear separation of the HM sample from the AR sample, with a slight trend of dissociation from the AR group ( Figure 5B ).

An analysis for the CD56 dim NK cell population was performed; patients with a high percentage showed a trend toward lower survival probability (log-rank HR = 2.436), but the difference was not statistically significant (log-rank p = 0.1831; 95% CI: 0.6553-9.055) (not shown).

In a sensitivity analysis that included all participants analysed in each study, the cumulative number of days of cough, which had shown a significant difference in the per-protocol of MA, no longer differed significantly between the two groups, whereas the cumulative number of days of sore throat, which was not significant in the per-protocol of MA, showed a trend toward reduction in the LC-Plasma group.

The plasma concentrations of CXCL2 confirmed the RNA sequencing (RNAseq) data, while other chemokines, such as CCL20, showed a trend that did not quite reach statistical significance ( Figure 6 ).

In a phase II trial in metastatic castration-resistant prostate cancer ( NCT00992186 ), free CCL2 showed a trend of rapid rebound despite a manageable safety profile ( 223 ).

Eta, but not cer or tocilizumab (toc, a humanized IgG1 against human IL-6R), also showed a strong trend of enhancing the expression of SIRPG in blasting CD4+ and CD8+ T cells ( Figures 2B, C , and S2C ).